CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing therapies to prevent cancer metastasis by targeting circulating tumor cell clusters. By screening FDA-approved compounds, the project aims to identify and patent effective agents that can disaggregate these clusters, potentially delaying or preventing metastatic spread in cancer patie…
Despite the great progress that has been made in treating cancer, metastasis remains incurable.
Metastasis accounts for 8 million deaths per year worldwide and no agents are currently available to prevent the metastatic spread of cancer.
The metastatic process begins with cancer cells leaving the primary tumor site and entering the blood circulation.
In circulation, cancer cells are defined as circulating tumor cells (CTCs), and are typically found in the form of single CTCs or small CTC aggrega…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
